APA (7th ed.) Citation

Ghosh, N., Postow, M., Zhu, C., Jannat-Khah, D., Li, Q., Vitone, G., . . . Bass, A. R. (2022). Lower baseline autoantibody levels are associated with immune-related adverse events from immune checkpoint inhibition. Journal for immunotherapy of cancer, 10(1), e004008. https://doi.org/10.1136/jitc-2021-004008

Chicago Style (17th ed.) Citation

Ghosh, Nilasha, Michael Postow, Chengsong Zhu, Deanna Jannat-Khah, Quan-Zhen Li, Greg Vitone, Karmela K. Chan, and Anne R. Bass. "Lower Baseline Autoantibody Levels Are Associated with Immune-related Adverse Events from Immune Checkpoint Inhibition." Journal for Immunotherapy of Cancer 10, no. 1 (2022): e004008. https://doi.org/10.1136/jitc-2021-004008.

MLA (9th ed.) Citation

Ghosh, Nilasha, et al. "Lower Baseline Autoantibody Levels Are Associated with Immune-related Adverse Events from Immune Checkpoint Inhibition." Journal for Immunotherapy of Cancer, vol. 10, no. 1, 2022, p. e004008, https://doi.org/10.1136/jitc-2021-004008.